All Blogs

Jul 11, 2025

Redefining PH-ILD Management: From Prostacyclins to Multi-mechanistic Innovations


Jul 10, 2025

Intuitive’s da Vinci 5 Gets CE Mark; Boston Scientific’s FARAPULSE™ Secures Expanded FDA Approval; Trividia Health’s TRUE METRIX® Added to Pennsylvania Medicaid List; Cerapedics’ PearlMatrix™ Sees First U.S. Clinical Use Post-FDA Nod; Smith+Nephew Expands Q-FIX◊ with Knotless Option; Cochlear Unveils World’s First Smart Cochlear Implant


Jul 09, 2025

The Rise of Menstrual Cups: Revolutionizing Healthcare and Sustainability


Jul 09, 2025

SUNRISE Trial: Eptinezumab Delivers Robust Migraine Prevention in Predominantly Asian Population


Jul 09, 2025

ALMB-0166: A First-in-Class Astrocyte-targeting Therapy Shows Promise in Acute Spinal Cord Injury


Jul 09, 2025

EAN 2025: Efgartigimod Add-on Shows Promising Efficacy in NMOSD and MOGAD during Acute Relapse


Jul 09, 2025

EAN 2025: Empasiprubart Shows Proof-of-concept in MMN with Reduced IVIg Dependence and Biomarker Improvements


Jul 09, 2025

EAN 2025: Riliprubart Shows Sustained and Broad Efficacy in CIDP across Subgroups


Jul 09, 2025

STEP UP: A Powerful Leap Forward for WEGOVY (semaglutide) in the Obesity Market


Jul 09, 2025

Orforglipron at American Diabetes Association (ADA): Pioneering the Next Generation of Oral, Nonpeptide GLP-1 Therapies